In 2023, Malaysia's external health expenditure stood at a certain baseline which formed the basis for forecasting future trends. The forecasted data from 2024 to 2028 indicates a gradual year-on-year increase in external health expenditure. From 2024 to 2025, the expenditure is expected to rise by approximately 3.57%, followed by a 3.45% increase from 2025 to 2026. Moving to 2026, the percentage increase is forecasted to be around 3.33% leading to 2027, and a 3.23% increase from 2027 to 2028. Over the five years from 2024 to 2028, the compounded annual growth rate (CAGR) is estimated to be around 3.4%, reflecting a consistent upward trend.
Future trends to watch for include potential shifts in government policy towards healthcare funding, economic conditions impacting external expenditures, and advancements in medical technology that could influence cost structures.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...